Public Market Listing
4503TSE
Live quotes, historical charts, and market capitalization for Astellas Pharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(7 total)
7Total Assets
2Approved
4Phase 3 / Filed
1Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Avacincaptad pegol(Izervay) | Approved | Complement C5Other | Age-Related Macular Degeneration |
| Approved | FLT3Small molecule | Non-Small Cell Lung CancerAcute Myeloid Leukemia | |
| Phase 3 | Phosphate binderSmall molecule | Chronic Kidney Disease | |
| Phase 3 | Nectin-4Antibody–drug conjugate | Non-Small Cell Lung Cancer | |
Roxadustat(Evrenzo) | Phase 3 | HIF prolyl hydroxylase (HIF-PH1/2/3)Small molecule | Chronic Kidney DiseaseMyelodysplastic Syndromes |
| Phase 3 | KRAS G12DSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | Pan-KRASSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.